Literature DB >> 8095047

Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein.

M K al-Shawi1, A E Senior.   

Abstract

A multidrug-resistant Chinese hamster ovary cell line (CR1R12) was obtained which constitutively expresses P-glycoprotein, up to 32% by weight of plasma membrane protein. CR1R12 plasma membranes had high, drug-activated ATPase activity referable to P-glycoprotein. The specific ATPase activity in the presence of verapamil was calculated to be approximately 9 mumol/min/mg (identical to 21 s-1) at 37 degrees C, pH 7.4. KM ATP was 1.4 mM, and ADP and 5'-adenylyl imidodiphosphate were competitive inhibitors with Ki values 0.35 and 0.44 mM, respectively. 2'-dATP was a good substrate, GTP and ITP were real but poor substrates, and ADP and AMP were not hydrolyzed. Optimal pH for ATP hydrolysis was 7.3. MgATP was the preferred substrate, and CaATP was hydrolyzed very weakly. 7-Chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) covalently labeled the P-glycoprotein, and incorporation of 1.1 mol of NBD-Cl/mol of P-glycoprotein gave 100% inactivation. ATP protected against NBD-Cl inactivation. N-Ethylmaleimide was a potent inhibitor in the absence of ATP, and in its presence significant protection from inhibition could be achieved. Vanadate and fluoroaluminate were also strong inhibitors. The plasma membranes from CR1R12 cells should provide material for purification and reconstitution of P-glycoprotein and for screening of potential "multidrug-reversal" reagents by enzymic assay.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095047

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Mechanism of coupling of transport to hydrolysis in bacterial ATP-binding cassette transporters.

Authors:  Amy L Davidson
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

Review 2.  Collateral sensitivity as a strategy against cancer multidrug resistance.

Authors:  Kristen M Pluchino; Matthew D Hall; Andrew S Goldsborough; Richard Callaghan; Michael M Gottesman
Journal:  Drug Resist Updat       Date:  2012-04-06       Impact factor: 18.500

3.  Functional expression of mouse Mdr1 in an outer membrane permeability mutant of Escherichia coli.

Authors:  O Béjà; E Bibi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 4.  Two ATPases.

Authors:  Alan E Senior
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 5.  ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

Authors:  Young Hee Choi; Ai-Ming Yu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

6.  A combination of curcumin with either gramicidin or ouabain selectively kills cells that express the multidrug resistance-linked ABCG2 transporter.

Authors:  Divya K Rao; Haiyan Liu; Suresh V Ambudkar; Michael Mayer
Journal:  J Biol Chem       Date:  2014-09-24       Impact factor: 5.157

7.  Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.

Authors:  M Ramachandra; S V Ambudkar; M M Gottesman; I Pastan; C A Hrycyna
Journal:  Mol Biol Cell       Date:  1996-10       Impact factor: 4.138

8.  Magnesium Adenosine 5[prime]-Triphosphate-Energized Transport of Glutathione-S-Conjugates by Plant Vacuolar Membrane Vesicles.

Authors:  Z. S. Li; Y. Zhao; P. A. Rea
Journal:  Plant Physiol       Date:  1995-04       Impact factor: 8.340

9.  P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol.

Authors:  Karsten Bucher; Sara Belli; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2007-05-12       Impact factor: 4.200

10.  Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.

Authors:  S Döppenschmitt; H Spahn-Langguth; C G Regårdh; P Langguth
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.